PAVMED INC. — Income Charts
3 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$71K
Cost of Revenue
$218K
Gross Profit
—
R&D
$4M
D&A
$105K
Operating Income
$-22M
EBITDA
$-22M
Interest Expense
$21K
Interest Income
$29K
Other Income/Expense
$19M
Pretax Income
$-2M
Tax Provision
$0
Net Income
$401K
Gross Margin
—
Operating Margin
-30712.7%
Net Margin
564.8%
Effective Tax Rate
0.0%
Deferred Tax Assets
$0
Deferred Tax Liabilities
$5K
DTA Valuation Allowance
$34M
Tax Credit Carryforwards
$3M
NOL Carryforwards
$28M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-1.1%
ETR Foreign Differential (pp)
0.0%
Operating Lease Cost
$692K
Revenue YoY Variation
-97.6%
Income YoY Variation
51.0%